These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 4367342

  • 1. An analysis of variables affecting the measurement of tumor immunity in vitro with 125I-iododeoxyuridine-labelled target cells. Studies of immunity to primary Moloney sarcomas.
    Seeger RC, Rayner SA, Owen JJ.
    Int J Cancer; 1974 May 15; 13(5):697-713. PubMed ID: 4367342
    [No Abstract] [Full Text] [Related]

  • 2. Cell-mediated anti-tumor immunity in oncornavirus-induced tumors: specific cytostasis of tumor cells by spleen amd lymph-node cells.
    Senik A, de Giorgi L, Levy JP.
    Int J Cancer; 1974 Sep 15; 14(3):386-95. PubMed ID: 4376520
    [No Abstract] [Full Text] [Related]

  • 3. Early appearance of a lymphoid arming factor and cytotoxic lymph-node cells after tumor induction.
    Pollack S, Nelson K.
    Int J Cancer; 1974 Oct 15; 14(4):522-9. PubMed ID: 4459277
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Cell-mediated immune reaction against tumors induced by oncornaviruses. 3. Studies by mixed lymphocyte-tumor reaction.
    Senik A, Gomard E, Plata F, Levy JP.
    Int J Cancer; 1973 Jul 15; 12(1):233-41. PubMed ID: 4133585
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antibody-dependent cell-mediated cytotoxicity in the Moloney sarcoma virus system: differential activity of IgG and IgM with different subpopulations of lymphocytes.
    Lamon EW, Shaw MW, Goodson S, Lidin B, Walia AS, Fuson EW.
    J Exp Med; 1977 Feb 01; 145(2):302-13. PubMed ID: 833543
    [Abstract] [Full Text] [Related]

  • 9. Cell-mediated immunity to Friend virus-induced leukemia.
    Ting CC, Shiu G, Rodrigues D, Herberman RB.
    Cancer Res; 1974 Jul 01; 34(7):1684-7. PubMed ID: 4134674
    [No Abstract] [Full Text] [Related]

  • 10. Specific killing of tumor cells in vitro in the presence of normal lymphoid cells and sera from hosts immune to the tumor antigens.
    Pollack S, Heppner G, Brawn RJ, Nelson K.
    Int J Cancer; 1972 Mar 15; 9(2):316-23. PubMed ID: 5041610
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cell-mediated and humoral immunity studies of murine and hamster sarcoma virus-induced producer and non-producer tumors in syngeneic animals.
    McCoy JL, Ting RC, McCoy NT, Reisher JI, Chan SP, Law LW.
    Int J Cancer; 1974 May 15; 13(5):731-41. PubMed ID: 4367343
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Specificity of 51Cr-release cytotoxicity of lymphocytes immune to murine sarcoma virus.
    Herberman RB, Aoki T, Nunn M, Lavrin DH, Soares N, Gazdar A, Holden H, Chang KS.
    J Natl Cancer Inst; 1974 Oct 15; 53(4):1103-11. PubMed ID: 4139276
    [No Abstract] [Full Text] [Related]

  • 19. The immune response to primary Moloney sarcoma virus tumors in BALB-c mice: cellular and humoral activity of long-term regressors.
    Lamon EW, Anderson B, Wigzell H, Fenyö EM, Klein E.
    Int J Cancer; 1974 Jan 15; 13(1):91-104. PubMed ID: 4594340
    [No Abstract] [Full Text] [Related]

  • 20. Primary and secondary in vitro generation of cytolytic T lymphocytes in the murine sarcoma virus system.
    Plata F, Cerottini JC, Brunner KT.
    Eur J Immunol; 1975 Apr 15; 5(4):227-33. PubMed ID: 185057
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.